Key Dates

Related Announcements

• April 23, 2024 - Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional). See NOFO RFA-DK-25-010. 

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this notice is to clarify the correct "Component for Submission" for the Biomedical Research Core and the Pilot and Feasibility Program (P and F Program). The following section of the NOFO has been revised:

Currently, Reads: 

Section IV. Application and Submission Information

2. Content and Form of Application Submission

Instructions for the Submission of Multi-Component Applications

Biomedical Research Core

When preparing your application in ASSIST, use Component Type ‘Biomedical Research Core’.

Pilot and Feasibility Program

When preparing your application in ASSIST, use Component Type ‘P and F Program’. 

Modified to Read (changes shown are bold and underlined):

Section IV. Application and Submission Information

2. Content and Form of Application Submission

Instructions for the Submission of Multi-Component Applications

Biomedical Research Core

When preparing your application in ASSIST, use Component Type ‘Core’.

Pilot and Feasibility Program

When preparing your application in ASSIST, use Component Type ‘Project’.

All other aspects of RFA-DK-25-010 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Thomas L Eggerman, MD, PhD.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8813
Email: [email protected]